Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
6.50
+0.21 (3.34%)
At close: Dec 18, 2025, 4:00 PM EST
6.54
+0.04 (0.62%)
After-hours: Dec 18, 2025, 7:56 PM EST
Niagen Bioscience Market Cap
Niagen Bioscience has a market cap or net worth of $520.58 million as of December 18, 2025. Its market cap has decreased by -9.86% in one year.
Market Cap
520.58M
Enterprise Value
459.50M
1-Year Change
-9.86%
Ranking
Category
Stock Price
$6.50
Market Cap Chart
Since June 25, 2008, Niagen Bioscience's market cap has decreased from $909.70M to $520.58M, a decrease of -42.77%. That is a compound annual growth rate of -3.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 502.00M | 23.89% |
| Dec 31, 2024 | 405.20M | 277.28% |
| Dec 29, 2023 | 107.40M | -14.15% |
| Dec 30, 2022 | 125.10M | -51.02% |
| Dec 31, 2021 | 255.40M | -13.89% |
| Dec 31, 2020 | 296.60M | 15.50% |
| Dec 31, 2019 | 256.80M | 35.87% |
| Dec 31, 2018 | 189.00M | -33.29% |
| Dec 29, 2017 | 283.30M | 125.74% |
| Dec 30, 2016 | 125.50M | -5.71% |
| Dec 31, 2015 | 133.10M | 41.45% |
| Dec 31, 2014 | 94.10M | -40.97% |
| Dec 31, 2013 | 159.40M | 224.64% |
| Dec 31, 2012 | 49.10M | 19.76% |
| Dec 30, 2011 | 41.00M | -49.88% |
| Dec 31, 2010 | 81.80M | 544.09% |
| Dec 31, 2009 | 12.70M | -95.35% |
| Dec 31, 2008 | 272.90M | -70.00% |
| Jun 25, 2008 | 909.70M | - |
View and export this data all the way back to 2008. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |